At 11:40 p.m., Kioo Pharmacy had been reduced to three sounds: the low hum of the medicine refrigerator, the receipt printer chirping every few minutes, and rain tapping the front windows. Leila Msuya was counting the night stock when the glass door burst open.
A young man staggered in clutching the counter as if the floor were moving beneath him. His jacket was wet, his face unnaturally hot. A black Nocturne Care bracelet circled his left wrist. He tried to speak, then one knee folded and he collapsed sideways.
“Nurse!” Leila shouted.
Asha ran from the injection room. Leila was already on her knees, checking his airway and asking his name.
“Elias. Elias Mbeki.”
His fist was closed around something. With gloves on, Leila eased it open and found an empty Calm-X ampoule. She placed it in a separate tray and recorded the time before anyone could throw it away.
“When did you inject this?”
“Twenty minutes. Maybe.”
“Where did you get it?”
“Not Nocturne today.”
The answer solved nothing. Asha took his pulse, temperature and oxygen level. His heart was racing and his skin was hot, but he remained responsive. Leila moved him onto the pharmacy examination bed and kept the rear route clear for the emergency team.
The Nocturne bracelet carried a service number. Normally the verification portal returned a name, major allergy alerts and the approved protocol. Leila entered the number.
RECORD NOT FOUND.
She checked every digit and tried again. Same result.
“Is this bracelet yours?”
“Yes.”
“Your name isn't appearing in the registry.”
“Their mistake, not mine.”
Leila turned to the ampoule. Calm-X, two milliliters. Batch CX-41N. A release date and distributor code sat beneath the main label. She wrote them into the adverse-event intake form before opening the lot ledger.
“Any more ampoules?”
“That was my last one.”
“How many doses this week?”
“I don't want to talk about Nocturne.”
“I'm asking about the medicine, not the company.”
He watched her for a moment. His fear was not only physical. It carried the guarded look of someone who had learned that every question could become another debt.
“Three times,” he said.
Leila explained that his symptoms required emergency assessment. Before Asha could transfer him through the internal corridor, Elias's phone lit up: NOCTURNE RESPONSE. He killed the call. Seconds later the pharmacy phone rang.
“We have a member experiencing an episode at your facility,” a calm male voice said. “Our ambulance is on the way.”
“Member name?”
“Elias Mbeki.”
“With his permission I can verify what is needed. He has not consented to transfer.”
“His protocol requires transfer to a Nocturne facility.”
“Protocol does not replace the decision of a competent patient. Kioo ER is inside this building.”
Leila told Elias exactly what Nocturne had said.
“I refuse their ambulance,” he said immediately. “Take me to your ER.”
Asha documented that the refusal was his, not the staff's.
Once Elias was gone, Leila opened the stock system. Kioo still held thirty-six CX-41N ampoules. Calm-X was a major night stabilizer for some patients with nocturnal changes. Holding the batch would leave the pharmacy dangerously thin on options.
But the label stopped her from returning it to the shelf.
She pulled up the formulation-change notice and compared its approval date with the batch release date. She did the arithmetic twice.
“Leila?” Asha called from the doorway. “ER wants to know if you recommend another Calm-X.”
“Not yet.”
“What about the stock?”
Leila looked at the boxes. Leaving them available might expose other patients if the event proved real. Freezing them without a documented basis could create a shortage of its own.
She opened the incident module and selected STOCK HOLD — PENDING REVIEW. Her stated basis was narrow: an adverse event involving the batch, a registry mismatch and a release-date discrepancy requiring verification. She did not write fraud. She did not write poison.
Together, she and Asha counted all thirty-six ampoules, sealed them in the hold cabinet and signed the seal with the time. Leila submitted the adverse-event report to the Pharmacy Board and notified the ER that the batch could not be used pending review.
The cost appeared instantly in red on the inventory screen: NIGHT STABILIZER COVERAGE: CRITICAL.
Before leaving for the ER, Leila held the label beneath the white light and read the dates aloud.
Approval: the fourteenth.
Release: the eleventh.
The batch had been released three days before the formulation was approved.